Ketamine and Midazolam Anesthesia in Pacific Martens (Martes caurina)

Jack A. Mortenson; Katie M. Moriarty

doi:10.7589/2014-02-031

Translator Disclaimer

1 January 2015 Ketamine and Midazolam Anesthesia in Pacific Martens (Martes caurina)

Jack A. Mortenson, Katie M. Moriarty

Author Affiliations +

J. of Wildlife Diseases, 51(1):250-254 (2015). https://doi.org/10.7589/2014-02-031

Abstract

The use of midazolam as a tranquilizer for anesthesia in mustelids in conjunction with the cyclohexamine ketamine is not well documented. Because midazolam is fast acting, inexpensive, and quickly metabolized, it may serve as a good alternative to other more commonly used tranquilizers. We trapped and anesthetized 27 Pacific martens (Martes caurina) in Lassen National Forest (northern California, US) August 2010–April 2013. We assessed anesthesia with ketamine at 18 and 25 mg/kg combined with 0.2 mg/kg of midazolam by comparing mean times of induction, return to consciousness, and recovery, plus physiologic parameters. No reversal was used for the midazolam portion of the anesthetic. Mean (±SD) induction for both ketamine dosages was 1.7±0.5 and 1.8±1.0 min, respectively. Return to consciousness mean times were 8.0 min longer (P<0.001) for martens receiving a 25 mg/kg ketamine dosage. Mean recoveries were 15.1 min longer (P<0.003) for the 25 mg/kg ketamine dosage. Physiologic parameter means were similar for both ketamine dosages with no statistically significant differences. Body temperatures and heart and respiratory rates were generally stable, but percentage of oxygen saturation and end tidal carbon dioxide values were below those seen in previous mustelid studies. The combination of ketamine, at both dosages, and midazolam provided reliable field anesthesia for Pacific martens, and supplemental oxygen is recommended as needed.

Wildlife Disease Association 2015

Citation Download Citation

Jack A. Mortenson and Katie M. Moriarty "Ketamine and Midazolam Anesthesia in Pacific Martens (Martes caurina)," Journal of Wildlife Diseases 51(1), (1 January 2015). https://doi.org/10.7589/2014-02-031

Received: 10 February 2014; Accepted: 1 June 2014; Published: 1 January 2015

ACCESS THE FULL ARTICLE

PERSONAL SIGN IN
Full access may be available with your subscription

Password Forgot your password?

Show

Remember Email on this computer

Remember Password

No BioOne Complete account? Create an account
or Access Institutional Sign In via Shibboleth or OpenAthens

PURCHASE THIS CONTENT

PURCHASE SINGLE ARTICLE

Price: $20.00 ADD TO CART

Includes PDF & HTML, when available

RIGHTS & PERMISSIONS

KEYWORDS/PHRASES

PUBLICATION TITLE:

PUBLICATION YEARS